Kenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancy

[ad_1]

A bottle of Johnson & Johnson Tylenol brand pain reliever.

Daniel Acker | Bloomberg | Getty Images

Shares of Kenvue fell more than 10% on Friday after a report that Robert F. Kennedy Jr. will likely link autism to the use of the company’s pain medication Tylenol in pregnant women. 

This is breaking news. Please refresh for updates.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *